Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance this year moved its annual shareholder's meeting from the Windy City to the snow-ridden streets of Manhattan, approving three proposals made by the board, reviewing the company's recent events and looking ahead to the future.

Photo: Marvin Ellison, CEO, J.C. Penney

Massage Envy on Monday named Joseph Magnacca CEO. Former CEO Dave Crisalli will continue to serve the business as a member of its board.

Walgreens Boots Alliance on Thursday reported net sales of $29 billion, representing an increase of 48.5%, for the first quarter 2016 that ended Nov. 30, 2015. The significant growth was attributed to the inclusion of Alliance Boots consolidated results, the company reported.

Walgreens Boots Alliance on Thursday reported net sales of $29 billion, representing an increase of 48.5%, for the first quarter 2016 that ended Nov. 30, 2015. The significant growth was attributed to the inclusion of Alliance Boots consolidated results, the company reported.

Wall Street had expected $29.2 billion in overall revenue, according to analysts polled by Thomson Reuters.

Alex Gourlay, Walgreens Boots Alliance's executive VP and Walgreens president, on Tuesday provided a snapshot of Walgreens U.S. market strategy, including how the proposed Rite Aid acquisition folds into that strategy, during the Credit Suisse 2015 Healthcare Conference here.

The Walgreens Boots Alliance/Rite Aid deal can pass Federal Trade Commission scrutiny with as little as 170 retail store divestitures, according to a proprietary analysis conducted by Credit Suisse, but the company will more likely be required to sell off some 950 stores.